Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
30
PharmaCompass offers a list of Icatibant Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Icatibant Acetate manufacturer or Icatibant Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icatibant Acetate manufacturer or Icatibant Acetate supplier.
A Icatibant Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icatibant Acetate, including repackagers and relabelers. The FDA regulates Icatibant Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icatibant Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Icatibant Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Icatibant Acetate supplier is an individual or a company that provides Icatibant Acetate active pharmaceutical ingredient (API) or Icatibant Acetate finished formulations upon request. The Icatibant Acetate suppliers may include Icatibant Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Icatibant Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Icatibant Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Icatibant Acetate active pharmaceutical ingredient (API) in detail. Different forms of Icatibant Acetate DMFs exist exist since differing nations have different regulations, such as Icatibant Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Icatibant Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Icatibant Acetate USDMF includes data on Icatibant Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Icatibant Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Icatibant Acetate suppliers with USDMF on PharmaCompass.
A Icatibant Acetate written confirmation (Icatibant Acetate WC) is an official document issued by a regulatory agency to a Icatibant Acetate manufacturer, verifying that the manufacturing facility of a Icatibant Acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Icatibant Acetate APIs or Icatibant Acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Icatibant Acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Icatibant Acetate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Icatibant Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Icatibant Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Icatibant Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Icatibant Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Icatibant Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Icatibant Acetate suppliers with NDC on PharmaCompass.
Icatibant Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Icatibant Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Icatibant Acetate GMP manufacturer or Icatibant Acetate GMP API supplier for your needs.
A Icatibant Acetate CoA (Certificate of Analysis) is a formal document that attests to Icatibant Acetate's compliance with Icatibant Acetate specifications and serves as a tool for batch-level quality control.
Icatibant Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Icatibant Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Icatibant Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Icatibant Acetate EP), Icatibant Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Icatibant Acetate USP).
